✦ LIBER ✦

Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study

✍ Scribed by L. G. Estévez; P. Sánchez-Rovira; M. Dómine; A. León; I. Calvo; A. Jaén; V. Casado; G. Rubio; M. Díaz; C. Miró; F. Lobo; E. Carrasco; M. Casillas; B. San Antonio

Publisher: Springer Milan
Year: 2007
Tongue: Spanish
Weight: 80 KB
Volume: 9
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-007-0059-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A dose-dense schedule of docetaxel follo

A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study

✍ Silvia Antolín; Ramón Mel; Manuel Ramos; Andrés García-Palomo; Concepción Almanz 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 118 KB

Doxorubicin and cyclophosphamide followe

Doxorubicin and cyclophosphamide followed by weekly docetaxel as neoadjuvant treatment of early breast cancer: analysis of biological markers in a GEICAM phase II study

✍ Laura G. Estevez; José Luis Fortes; Encarna Adrover; Gloria Peiró; Mireia Margel 📂 Article 📅 2009 🏛 Springer Milan 🌐 Spanish ⚖ 244 KB

Fifteen-year median follow-up results af

Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)

✍ G. G. Kimmick; C. Cirrincione; D. B. Duggan; K. Bhalla; N. Robert; D. Berry; L. 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 325 KB

Phase 2 study of neoadjuvant treatment w

Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer

✍ A. J. Montero; C. M. Diaz-Montero; Y. E. Deutsch; J. Hurley; L. G. Koniaris; T. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 398 KB

A phase II study of sequential docetaxel

A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer

✍ Eleni M. Karapanagiotou; Adrianni Charpidou; Ifigenia Tzannou; Kalliopi Dilana; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 159 KB

Phase II study of dose-dense doxorubicin

Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer

✍ Jesús García-Mata; Andrés García-Palomo; Lourdes Calvo; Ramón Mel; Juan Jesús Cr 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 240 KB